Sumitomo Pharma Co. Ltd

Sumitomo Pharma Co. Ltd

World Rank (Jan-05-2024)
7,290
Market Cap (Jan-05-2024)
1.330 Billion USD
World Rank (Jul-30-2023)
6,035
Market Cap (Jul-30-2023)
1.845 Billion USD
World Rank (Jan-07-2022)
3,494
Market Cap (Jan-07-2022)
4.618 Billion USD
World Rank (Jan-01-2021)
2,616
Market Cap (Jan-01-2021)
5.842 Billion USD
Company Rank in Country in 2023
Rank in Japan in 2023 is 452
Headquarters Country
Japan
Market Cap (Mar-08-2026)
4.83
Employee Count
6,646
Employee Count as of Date
3,074 employees on standalone basis and has 6,646 employees on consolidated basis as on December 2020.
World Region
Asia
World Subregion
Eastern Asia
Annual Revenue in USD
4,087 Million USD
Annual Net Income in USD
412 Million USD
Annual Results for Period Ending
Mar-2022 ending year
Total Assets in USD
9,545 Million USD
Total Liabilities in USD
4,629 Million USD
Total Equity in USD
4,915 Million USD
Balance Sheet for Period Ending
Mar-2022 ending year
Business Sector
Healthcare
Pharmaceutical
Company Website
SUMITOMO DAINIPPON PHARMA
Yahoo
Yahoo @ OTC
Company Profile

Sumitomo Dainippon Pharma is a Pharmaceutical company. It manufactures and sales pharmaceuticals, food ingredients, food additives, veterinary medicines and others. The company has market capitalization is 22.4 billion yen and has around 3,074 employees on standalone basis and has 6,646 employees on consolidated basis as on December 2020. The headquarters is in Japan.

SUMITOMO DAINIPPON PHARMA was renamed to SUMITOMO PHARMA CO., LTD in April-2022.

Founded Year
2005
Stock Category
NIKKEI 225
Stock Exchange
Tokyo

Share